Fortress Biotech, Inc. (FBIO) Fair Value 2026

FBIO · Biotechnology ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.5 /10

32 fundamental signals · 2 models active

Value Trap Risk

LOW (30/100)

Quick Summary — As of 2026-08-28, Fortress Biotech, Inc. (FBIO) trades at $2.77, versus a $7.69 median fair value across its 2 active models — 177.6% above the current price. QOC: 6.5/10. Value Trap Risk: 30/100 (LOW). 2/13 models active.

Key Facts

Ticker
FBIO
Price
$2.77
Quality Score
6.5/10
Value Trap Risk
30/100
Models Active
2/13
Last Updated
Strength: PWERM suggests +189.1% upside with 32% confidence
Risk: Limited model coverage (2/13) may reduce confidence

Is Fortress Biotech, Inc. (FBIO) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, Fortress Biotech, Inc. (FBIO) appears undervalued as of : the median of 2 independent fair value estimates is $7.69, 177.6% above the current price of $2.77. Estimates range from $7.37 to $8.01. FBIO scores 6.5/10 on fundamental quality and 30/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.4% versus its own 13-model consensus, across 3,809 rated companies as of 2026-08-28. FBIO’s +177.6% gap is wider than that market norm, and the Biotechnology sector median is -64.7%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Fortress Biotech, Inc. Stock in 2026? →

What Fair Value Does Each Model Give FBIO?

2 Intrinsic Value Models vs. Current Price ($2.77)

Core Models (Unlocked)
Model Fair Value Upside
Option-Based · Medium Conviction
 $8.01 +189.1%
Relative · Low Conviction
 $7.37 +166.1%

All Models Active

All 2 models are displayed above.

What Is Fortress Biotech, Inc. (FBIO) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for Fortress Biotech, Inc.. Trading at $2.77 against an estimated intrinsic value of $7.69, 2 of 2 active models flag meaningful upside of +177.6% at the median.

What Do the Models Say About FBIO?

2 of 13 models are currently active for FBIO. All 2 active models suggest the stock trades below fair value. Taken together, their median fair value for FBIO is $7.69 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does FBIO Rank in Biotechnology?

Among 625 Biotechnology stocks, FBIO ranks #87 by Quality of Company score. CirclFi's QOC score of 6.5/10 evaluates 32 fundamental signals. A score of 6.5 indicates above-average quality.

See all Most Undervalued Biotechnology Stocks →

The Biotechnology sector introduces analytical considerations specific to biotech businesses. For Fortress Biotech, Inc., metrics like clinical trial success rate provide important context that general-purpose valuation models may underweight.

Is FBIO a Value Trap?

CirclFi's Value Trap algorithm assigns FBIO a score of 30/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for Fortress Biotech, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Fortress Biotech, Inc. scores 6.5 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

Models cluster within a tight range (+23.1% spread), increasing conviction. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every FBIO valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across FBIO's 2 active models, average confidence is 25%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Fortress Biotech, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Biotechnology Stocks Should You Also Analyze?

11 related Biotechnology stocks with 13-model coverage

ARDXArdelyx, Inc.QOC 6.5RXRXRecursion Pharmaceuticals, Inc.QOC 6.5ASNDAscendis Pharma A/SQOC 6.5SNDXSyndax Pharmaceuticals, Inc.QOC 6.5ZVRAZevra Therapeutics, Inc.QOC 6.5AGIOAgios Pharmaceuticals, Inc.QOC 6.5ZIVOZIVO Bioscience, Inc.QOC 5.4RZLTRezolute, Inc.QOC 4.7TVGNTevogen Bio Holdings Inc.QOC 3.8EXELExelixis, Inc.QOC 9.6INCYIncyte CorporationQOC 9.5

Read investment analysis: ARDX · RXRX · ASND · SNDX · ZVRA · AGIO · ZIVO · RZLT · TVGN · EXEL · INCY

Which Other Stocks Have a Similar Quality Score to FBIO?

6 companies across all industries closest to FBIO’s Quality of Company score of 6.5/10.

CRMTAmerica's Car-Mart, Inc.QOC 6.5FLRFluor CorporationQOC 6.5PLAYDave & Buster's Entertainment, Inc.QOC 6.5IPInternational Paper CompanyQOC 6.5ABITAthena Bitcoin GlobalQOC 6.5NVDANVIDIA CorporationQOC 10.0

Read investment analysis: CRMT · FLR · PLAY · IP · ABIT · NVDA

Where Does FBIO Sit in CirclFi's Biotechnology Rankings?

FBIO is ranked against every other Biotechnology stock CirclFi covers in each of these screens.

See all Biotechnology stocks ranked →

What Else Do Investors Ask About Fortress Biotech, Inc.’s Valuation?

What is Fortress Biotech, Inc.'s intrinsic value in 2026?

CirclFi puts Fortress Biotech, Inc. (FBIO)'s intrinsic value at $7.69 — the median of 2 independent model estimates as of 2026-08-28, ranging from $7.37 to $8.01. The Quality of Company score is 6.5/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is FBIO overvalued or undervalued right now?

At $2.77, 2 of 2 active models suggest FBIO may be undervalued, while 0 indicate potential overvaluation. The median of all 2 fair value estimates is $7.69, 177.6% above the current price of $2.77 — a consensus view that FBIO is undervalued. The assessment depends on which methodology best fits Fortress Biotech, Inc.'s business model in Biotechnology.

What does a Quality of Company score of 6.5 mean for FBIO?

Fortress Biotech, Inc.'s QOC of 6.5/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on FBIO?

CirclFi analyzes FBIO with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is FBIO a value trap in 2026?

Fortress Biotech, Inc.'s Value Trap score is 30/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, Fortress Biotech, Inc. (FBIO) has a median fair value of $7.69 — 177.6% above the current price of $2.77 — as of 2026-08-28.” Source: circlfi.com/stock/FBIO/ · Methodology
Primary sources for this FBIO valuation
  • Financial statements: Fortress Biotech, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001429260) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for FBIO as of ; valuations recomputed .